Release Date: 22/02/18 18:37 Summary: Change of Director's Interest Notice BS Price Sensitive: No Download Document 24.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%